{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T17:50:31Z","timestamp":1775325031683,"version":"3.50.1"},"reference-count":100,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:00:00Z","timestamp":1545177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Prognostic models or risk scores are frequently used to aid individualize risk assessment for diseases with multiple, complex risk factors and diagnostic challenges. However, relatively little attention has been paid to the development of risk models for invasive mold diseases encountered in patients with hematological malignancies, despite a large body of epidemiological research. Herein we review recent studies that have described the development of prognostic models for mold disease, summarize our experience with the development and clinical use of one such model (BOSCORE), and discuss the potential impact of prognostic risk scores for individualized therapy, diagnostic and antifungal stewardship, as well as clinical and epidemiological research.<\/jats:p>","DOI":"10.3390\/jof4040141","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T12:12:44Z","timestamp":1545221564000},"page":"141","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development and Applications of Prognostic Risk Models in the Management of Invasive Mold Disease"],"prefix":"10.3390","volume":"4","author":[{"given":"Marta","family":"Stanzani","sequence":"first","affiliation":[{"name":"Institute of Hematology \u201cLorenzo e Ariosto Ser\u00e0gnoli\u201d, Department of Hematology and Clinical Oncology, S. Orsola-Malpighi Hospital, University of Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2002-4339","authenticated-orcid":false,"given":"Russell E.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, Department of Medical and Surgical Sciences, S. Orsola-Malpighi Hospital, University of Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,12,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"i19","DOI":"10.1093\/jac\/dkx030","article-title":"Early diagnosis of invasive mould infections and disease","volume":"72","author":"Lamoth","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dkq437","article-title":"Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients","volume":"66","author":"Pagano","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1749-6632.2012.06829.x","article-title":"Risk stratification for invasive aspergillosis in immunocompromised patients","volume":"1272","author":"Herbrecht","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2016.09.002","article-title":"Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations","volume":"31","author":"Pagano","year":"2016","journal-title":"Blood Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10096-007-0270-z","article-title":"Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting","volume":"26","author":"Sable","year":"2007","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/cid\/ciu074","article-title":"MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting","volume":"58","author":"Shoham","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","article-title":"A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization","volume":"34","author":"Saavedra","year":"2006","journal-title":"Crit. Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jcrc.2015.03.010","article-title":"Development and validation of a clinical prediction rule for candidemia in hospitalized patients with severe sepsis and septic shock","volume":"30","author":"Guillamet","year":"2015","journal-title":"J. Crit. Care"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/bmj.b375","article-title":"Prognosis and prognostic research: What, why, and how?","volume":"338","author":"Moons","year":"2009","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Tutorial in biostatistics multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/myc.12820","article-title":"EQUAL Aspergillosis Score 2018: An ECMM score derived from current guidelines to measure QUALity of the clinical management of invasive pulmonary aspergillosis","volume":"61","author":"Cornely","year":"2018","journal-title":"Mycoses"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Stanzani, M., Lewis, R.E., Fiacchini, M., Ricci, P., Tumietto, F., Viale, P., Ambretti, S., Baccarani, M., Cavo, M., and Vianelli, N. (2013). A risk prediction score for invasive mold disease in patients with hematological malignancies. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075531"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2014.113399","article-title":"Pre-chemotherapy risk factors for invasive fungal diseases: Prospective analysis of 1192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study)","volume":"100","author":"Caira","year":"2015","journal-title":"Haematologica"},{"key":"ref_17","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: The SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"ref_18","first-page":"862","article-title":"Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program","volume":"86","author":"Pagano","year":"2001","journal-title":"Haematologica"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/cid\/ciy473","article-title":"Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions","volume":"67","author":"Lionakis","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/ajh.25214","article-title":"Acute myeloid leukemia: 2019 update on risk-stratification and management","volume":"93","author":"Estey","year":"2018","journal-title":"Am. J. Hematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clml.2013.09.014","article-title":"Patterns of infection in patients with myelodysplastic syndromes and acute myeloid leukemia receiving azacitidine as salvage therapy. Implications for primary antifungal prophylaxis","volume":"14","author":"Falantes","year":"2014","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1080\/10428194.2017.1295141","article-title":"Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes","volume":"58","author":"Trubiano","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/myc.12500","article-title":"Invasive fungal infections in AML\/MDS patients treated with azacitidine: A risk worth considering antifungal prophylaxis?","volume":"59","author":"Pomares","year":"2016","journal-title":"Mycoses"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/jac\/dkx133","article-title":"Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia","volume":"72","author":"Cornely","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2141.2009.07712.x","article-title":"Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen","volume":"146","author":"Storring","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1016\/S2352-3026(18)30132-7","article-title":"Cladribine and low-dose cytarabine alternating with decitabine as front-line therapy for elderly patients with acute myeloid leukaemia: A phase 2 single-arm trial","volume":"5","author":"Kadia","year":"2018","journal-title":"Lancet Haematol"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1200\/JCO.2010.28.1287","article-title":"Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09\/00","volume":"28","author":"Bassan","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1182\/blood-2011-05-351403","article-title":"Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"118","author":"Vitale","year":"2011","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1182\/blood-2001-12-0181","article-title":"A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome\u2013positive acute lymphoid leukemias","volume":"100","author":"Ottmann","year":"2002","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e462","DOI":"10.3324\/haematol.2015.126698","article-title":"Epidemiology of invasive fungal disease in lymphoproliferative disorders","volume":"100","author":"Teng","year":"2015","journal-title":"Haematologica"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cid\/cix687","article-title":"Call for Action: Invasive Fungal Infections Associated with Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways","volume":"66","author":"Chamilos","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Teh, B.W., Tam, C.S., Handunnetti, S., Worth, L.J., and Slavin, M.A. (2018). Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapies. Blood Rev.","DOI":"10.1016\/j.blre.2018.04.007"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1400376","article-title":"Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia","volume":"371","author":"Byrd","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1182\/blood-2013-06-511592","article-title":"Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)","volume":"123","author":"Jabbour","year":"2014","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ajh.24572","article-title":"Risk factors for infections in myelofibrosis: Role of disease status and treatment. A multicenter study of 507 patients","volume":"92","author":"Polverelli","year":"2017","journal-title":"Am. J. Hematol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/j.seminhematol.2009.03.008","article-title":"Infections in patients with aplastic anemia","volume":"46","author":"Valdez","year":"2009","journal-title":"Semin. Hematol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/cid\/ciq245","article-title":"Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades","volume":"52","author":"Valdez","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkp074","article-title":"The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: The early years","volume":"63","author":"Bodey","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0021-9681(66)90066-X","article-title":"Fungal infections complicating acute leukemia","volume":"19","author":"Bodey","year":"1966","journal-title":"J. Chronic Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-100-3-345","article-title":"Prolonged granulocytopenia: The major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia","volume":"100","author":"Gerson","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/bmt.2009.39","article-title":"Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: An analysis of 306 patients","volume":"44","author":"Mikulska","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1086\/591969","article-title":"Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: Biological risk factors for infection according to time after transplantation","volume":"47","author":"Upton","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/myc.12101","article-title":"Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis","volume":"57","author":"Lewis","year":"2014","journal-title":"Mycoses"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.7326\/0003-4819-101-3-334","article-title":"Opportunistic infections in endogenous Cushing\u2019s syndrome","volume":"101","author":"Graham","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","article-title":"Epidemiology of invasive aspergillosis in critically ill patients: Clinical presentation, underlying conditions, and outcomes","volume":"19","author":"Taccone","year":"2015","journal-title":"Crit. Care"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Bassetti, M., Garnacho-Montero, J., Calandra, T., Kullberg, B., Dimopoulos, G., Azoulay, E., Chakrabarti, A., Kett, D., Leon, C., and Ostrosky-Zeichner, L. (2017). Intensive care medicine research agenda on invasive fungal infection in critically ill patients. Intensive Care Med., 1\u201314.","DOI":"10.1007\/s00134-017-4731-2"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2002-05-1496","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors","volume":"100","author":"Marr","year":"2002","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/516480","article-title":"Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation","volume":"175","author":"Wald","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/515116","article-title":"Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation","volume":"28","author":"Ribaud","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/sj.bmt.1702654","article-title":"Invasive fungal infections in pediatric bone marrow transplant recipients: Single center experience of 10 years","volume":"26","author":"Hovi","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1200\/JCO.1994.12.4.827","article-title":"Prediction of systemic fungal infection in allogeneic marrow recipients: Impact of amphotericin prophylaxis in high-risk patients","volume":"12","author":"Schmidt","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bbmt.2014.03.004","article-title":"Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: A prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)","volume":"20","author":"Girmenia","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/tid.12328","article-title":"Risk factors for invasive mold diseases in allogeneic hematopoietic cell transplant recipients","volume":"17","author":"Atalla","year":"2015","journal-title":"Transpl. Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood.V99.8.2726","article-title":"Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation","volume":"99","author":"Bittencourt","year":"2002","journal-title":"Blood"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Kuster, S., Stampf, S., Gerber, B., Baettig, V., Weisser, M., Gerull, S., Medinger, M., Passweg, J., Schanz, U., and Garzoni, C. (2018). Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study. Transpl. Infect. Dis., e12981.","DOI":"10.1111\/tid.12981"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1056\/NEJMoa0802629","article-title":"Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation","volume":"359","author":"Bochud","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1182\/blood-2010-04-279307","article-title":"Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity","volume":"116","author":"Cunha","year":"2010","journal-title":"Blood"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1211161","article-title":"Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation","volume":"370","author":"Cunha","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/bmt.2008.193","article-title":"The role of liver biopsy in the workup of liver dysfunction late after SCT: Is the role of iron overload underestimated?","volume":"42","author":"Sucak","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/cncr.22909","article-title":"Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation","volume":"110","author":"Kontoyiannis","year":"2007","journal-title":"Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/infdis\/jiv143","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation and association with occurrence and outcome of invasive aspergillosis","volume":"212","author":"Stuehler","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSET)","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/bmt.2008.303","article-title":"Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT","volume":"43","author":"Gil","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.3324\/haematol.2014.114025","article-title":"Invasive fungal infections in patients with multiple myeloma: A multi-center study in the era of novel myeloma therapies","volume":"100","author":"Teh","year":"2015","journal-title":"Haematologica"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/dmrr.682","article-title":"Common infections in diabetes: Pathogenesis, management and relationship to glycaemic control","volume":"23","author":"Peleg","year":"2007","journal-title":"Diabetes. Metab. Res. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.mib.2011.07.004","article-title":"Host cell invasion in mucormycosis: Role of iron","volume":"14","author":"Ibrahim","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2337\/diacare.31.12.1109","article-title":"A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: Transferrin and iron availability","volume":"31","author":"Artis","year":"1982","journal-title":"Diabetes"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/myc.12318","article-title":"Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: A single-centre study with focus on emerging pathogens","volume":"58","author":"Satlin","year":"2015","journal-title":"Mycoses"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/QCO.0000000000000502","article-title":"Invasive fungal disease and cytomegalovirus infection: Is there an association?","volume":"31","author":"Yong","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bmt.2009.78","article-title":"Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT","volume":"44","author":"Martino","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jmv.23735","article-title":"An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting","volume":"86","author":"Solano","year":"2014","journal-title":"J. Med. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11908-018-0610-4","article-title":"Immune Monitoring for CMV in Transplantation","volume":"20","author":"Yong","year":"2018","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S2213-2600(18)30332-1","article-title":"Let\u2019s add invasive aspergillosis to the list of influenza complications","volume":"6","author":"Lamoth","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: A retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcrc.2018.08.017","article-title":"Clinical characteristics, evolution, and treatment-related risk factors for mortality among immunosuppressed patients with influenza A (H1N1) virus admitted to the intensive care unit","volume":"48","author":"Vidaur","year":"2018","journal-title":"J. Crit. Care"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1093\/cid\/cir485","article-title":"Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients","volume":"53","author":"Barba","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"ofw171","DOI":"10.1093\/ofid\/ofw171","article-title":"Invasive Aspergillosis associated with severe influenza infections","volume":"3","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.arcmed.2009.10.001","article-title":"Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses","volume":"40","author":"Guarner","year":"2009","journal-title":"Arch. Med. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1086\/652761","article-title":"Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation","volume":"50","author":"Panackal","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"13958","DOI":"10.1038\/srep13958","article-title":"In silico modeling of spore inhalation reveals fungal persistence following low dose exposure","volume":"5","author":"Tanaka","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/cid\/civ297","article-title":"Review of Fungal Outbreaks and Infection Prevention in Healthcare Settings during Construction and Renovation","volume":"61","author":"Kanamori","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/jhin.2001.0998","article-title":"Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients","volume":"48","author":"Alberti","year":"2001","journal-title":"J. Hosp. Infect."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1086\/501661","article-title":"Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation","volume":"20","author":"Cornet","year":"1999","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1200\/JCO.2008.21.0856","article-title":"Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve","volume":"27","author":"Portugal","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.bjid.2016.04.007","article-title":"Diagnostic-driven antifungal therapy in neutropenic patients using the D-index and serial serum galactomannan testing","volume":"20","author":"Garnica","year":"2016","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00277-014-2093-1","article-title":"A novel scoring system to predict the incidence of invasive fungal disease in salvage chemotherapies for malignant lymphoma","volume":"93","author":"Takaoka","year":"2014","journal-title":"Ann. Hematol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/bjh.13356","article-title":"Computerized tomographic pulmonary angiography discriminates invasive mould disease of the lung from lymphoma","volume":"169","author":"Sassi","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/bmt.2015.181","article-title":"Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis","volume":"50","author":"Montesinos","year":"2015","journal-title":"Bone Marrow Transpl."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/bmt.2013.136","article-title":"Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients","volume":"49","author":"Hol","year":"2014","journal-title":"Bone Marrow Transpl."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1200\/JCO.2013.53.8157","article-title":"Comorbidity-age index: A clinical measure of biologic age before allogeneic hematopoietic cell transplantation","volume":"32","author":"Sorror","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/s41409-018-0161-1","article-title":"Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting","volume":"53","author":"Busca","year":"2018","journal-title":"Bone Marrow Transpl."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/bmj.b606","article-title":"Prognosis and prognostic research: Application and impact of prognostic models in clinical practice","volume":"338","author":"Moons","year":"2009","journal-title":"BMJ"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/cid\/ciu673","article-title":"Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective anti-mold prophylaxis","volume":"59","author":"Duarte","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/cid\/civ154","article-title":"High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies","volume":"60","author":"Stanzani","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): Explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"b605","DOI":"10.1136\/bmj.b605","article-title":"Prognosis and prognostic research: Validating a prognostic model","volume":"338","author":"Altman","year":"2009","journal-title":"BMJ"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e01122-17","DOI":"10.1128\/JCM.01122-17","article-title":"Predicting Invasive Aspergillosis in Hematology Patients by Combining Clinical and Genetic Risk Factors with Early Diagnostic Biomarkers","volume":"56","author":"White","year":"2018","journal-title":"J. Clin. Microbiol."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/4\/4\/141\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T16:51:00Z","timestamp":1775321460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/4\/4\/141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,19]]},"references-count":100,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["jof4040141"],"URL":"https:\/\/doi.org\/10.3390\/jof4040141","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,19]]}}}